PTGX · Protagonist Therapeutics, Inc · Documents
$138.96
+4.52 (+3.36%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$8.70B
Shares
64.71M
Volume · Oct 20
411.23K
Avg daily vol (3M)
636.56K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-11-02 | — | |
| 8-K | — | 2023-10-30 | 2023-10-26 | |
| 8-K | — | 2023-08-03 | — | |
| 10-Q | — | 2023-08-03 | 2023-06-30 | |
| 8-K | — | 2023-07-05 | 2023-07-04 | |
| 8-K | — | 2023-07-03 | 2023-06-27 | |
| 8-K | — | 2023-05-30 | 2023-05-25 | |
| 10-Q | — | 2023-05-04 | 2023-03-31 | |
| 8-K | — | 2023-05-04 | — | |
| ARS | — | 2023-04-12 | 2022-12-31 | |
| DEFA14A | — | 2023-04-12 | — | |
| DEF 14A | — | 2023-04-12 | 2023-05-25 | |
| 8-K | — | 2023-04-10 | 2023-04-04 | |
| 8-K | — | 2023-03-15 | — | |
| 10-K | — | 2023-03-15 | 2022-12-31 | |
| 8-K | — | 2023-03-10 | — | |
| 8-K | — | 2023-01-06 | 2023-01-01 | |
| 8-K | — | 2022-11-08 | — | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| S-3 | — | 2022-08-05 | — | |
| 8-K | — | 2022-08-04 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-06-02 | 2022-05-26 | |
| 10-Q | — | 2022-05-05 | 2022-03-31 | |
| 8-K | — | 2022-05-04 | — | |
| 8-K | — | 2022-04-26 | 2022-04-25 | |
| DEFA14A | — | 2022-04-13 | — | |
| 8-K | — | 2022-04-13 | — | |
| DEF 14A | — | 2022-04-13 | 2022-05-26 | |
| 8-K | — | 2022-03-31 | 2022-03-25 | |
| 8-K | — | 2022-03-23 | 2022-03-17 | |
| 10-K | — | 2022-02-28 | 2021-12-31 | |
| 8-K | — | 2022-02-28 | — | |
| 8-K | — | 2022-02-22 | 2022-02-15 | |
| 10-Q | — | 2021-11-03 | 2021-09-30 | |
| 8-K | — | 2021-11-03 | — | |
| 8-K | — | 2021-09-17 | — | |
| 8-K | — | 2021-08-10 | 2021-08-04 | |
| 10-Q | — | 2021-08-04 | 2021-06-30 | |
| 8-K | — | 2021-08-04 | — | |
| 8-K | — | 2021-07-28 | 2021-07-27 | |
| 8-K | — | 2021-06-17 | 2021-06-15 | |
| 8-K | — | 2021-06-14 | — | |
| 8-K | — | 2021-05-28 | 2021-05-27 | |
| 8-K | — | 2021-05-04 | — | |
| 10-Q | — | 2021-05-04 | 2021-03-31 | |
| DEF 14A | — | 2021-04-14 | 2021-05-27 | |
| DEFA14A | — | 2021-04-14 | — | |
| 8-K | — | 2021-03-10 | — | |
| 10-K | — | 2021-03-10 | 2020-12-31 |
Showing 51–100 of 119 filings
Key facts
CIK
1377121
CUSIP
74366E102
13F (30d)
30 filings
30 filers
Visit website
Investor relations